TY  - GEN
AU  - Chang,Yong S
AU  - Adnane,Jalila
AU  - Trail,Pamela A
AU  - Levy,Joan
AU  - Henderson,Arris
AU  - Xue,Dahai
AU  - Bortolon,Elizabeth
AU  - Ichetovkin,Marina
AU  - Chen,Charles
AU  - McNabola,Angela
AU  - Wilkie,Dean
AU  - Carter,Christopher A
AU  - Taylor,Ian C A
AU  - Lynch,Mark
AU  - Wilhelm,Scott
TI  - Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models
SN  - 0344-5704
PY  - 2007///0522
KW  - Actins
KW  - metabolism
KW  - Adenocarcinoma, Clear Cell
KW  - blood supply
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Animals
KW  - Antineoplastic Agents
KW  - Benzenesulfonates
KW  - Capillaries
KW  - pathology
KW  - Cell Line, Tumor
KW  - Female
KW  - Humans
KW  - Hypoxia
KW  - chemically induced
KW  - Immunohistochemistry
KW  - In Situ Nick-End Labeling
KW  - Kidney Neoplasms
KW  - Mice
KW  - Mice, Nude
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Platelet Endothelial Cell Adhesion Molecule-1
KW  - immunology
KW  - Pyridines
KW  - Regional Blood Flow
KW  - drug effects
KW  - Sorafenib
KW  - Vascular Endothelial Growth Factor A
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1007/s00280-006-0393-4
ER  -